Firm News

The Latest News from Lucosky Brookman

Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions.  Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here. 

Lucosky Brookman LLP Successfully Represents EF Hutton in $16.5 Million Registered Direct Offering of Odyssey Marine Exploration, Inc.

Lucosky Brookman LLP Successfully Represents EF Hutton in $16.5 Million Registered Direct Offering of Odyssey Marine Exploration, Inc.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $16.5 million registered…

Read More
Lucosky Brookman LLP Successfully Represents EF Hutton in $4 Million Offering of TC Biopharm (Holdings) PLC American Depositary Shares (ADS)

Lucosky Brookman LLP Successfully Represents EF Hutton in $4 Million Offering of TC Biopharm (Holdings) PLC American Depositary Shares (ADS)

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $4 million underwritten…

Read More
Lucosky Brookman Successfully Represents Aegis Capital Corp. in Pricing of $10 Million Public Offering and Nasdaq Listing of SOBR Safe, Inc.

Lucosky Brookman Successfully Represents Aegis Capital Corp. in Pricing of $10 Million Public Offering and Nasdaq Listing of SOBR Safe, Inc.

Lucosky Brookman LLP congratulates SOBR Safe, Inc. (NASDAQ: SOBR), providers of innovative solutions for alcohol policy management, on its…

Read More
Lucosky Brookman Successfully Represents Modular Medical, Inc. Close $8 Million Registered Direct Offering

Lucosky Brookman Successfully Represents Modular Medical, Inc. Close $8 Million Registered Direct Offering

Lucosky Brookman LLP congratulates its client, Modular Medical, Inc. (NASDAQ: MODD), a development-stage insulin pump company focused on…

Read More
Lucosky Brookman Successfully Represents Vivakor, Inc. Close $8 Million Public Offering and Nasdaq Uplisting

Lucosky Brookman Successfully Represents Vivakor, Inc. Close $8 Million Public Offering and Nasdaq Uplisting

Lucosky Brookman LLP congratulates its client, Vivakor, Inc. (NASDAQ: VIVK), a socially responsible operator, acquirer and developer of clean…

Read More
Lucosky Brookman Successfully Represents Modular Medical, Inc. Close $15 Million Public Offering and Nasdaq Uplisting

Lucosky Brookman Successfully Represents Modular Medical, Inc. Close $15 Million Public Offering and Nasdaq Uplisting

Lucosky Brookman LLP congratulates its client, Modular Medical, Inc. (NASDAQ: MODD), a development-stage insulin pump company focused on…

Read More
Lucosky Brookman LLP Successfully Represents EF Hutton in $16.3 Million Initial Public Offering and Nasdaq Listing of TC Biopharm

Lucosky Brookman LLP Successfully Represents EF Hutton in $16.3 Million Initial Public Offering and Nasdaq Listing of TC Biopharm

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $16.3 million initial public…

Read More
Lucosky Brookman Successfully Represents American Rebel Holdings, Inc. in Pricing of $10.5 Million Public Offering and Nasdaq Listing

Lucosky Brookman Successfully Represents American Rebel Holdings, Inc. in Pricing of $10.5 Million Public Offering and Nasdaq Listing

Lucosky Brookman LLP congratulates its client, American Rebel Holdings, Inc. (NASDAQ: AREB; AREBW), a designer and marketer of branded safes…

Read More
Lucosky Brookman Successfully Represents BiondVax Pharmaceuticals Ltd. in Closing of $9.8 million Follow-on Underwritten Offering of ADSs

Lucosky Brookman Successfully Represents BiondVax Pharmaceuticals Ltd. in Closing of $9.8 million Follow-on Underwritten Offering of ADSs

Lucosky Brookman LLP congratulates its client, BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) on its successful closing of an underwritten…

Read More
Lucosky Brookman Successfully Represents EF Hutton in $8.0 Million Public Offering of Applied UV, Inc.

Lucosky Brookman Successfully Represents EF Hutton in $8.0 Million Public Offering of Applied UV, Inc.

Lucosky Brookman congratulates its client, EF Hutton on its successful public offering of $8.0 million of common stock of Applied UV, Inc.…

Read More